David R. Paolino
Director/Board Member at Elucid Bioimaging, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Andrew Buckler | M | - |
Elucid Bioimaging, Inc.
 Elucid Bioimaging, Inc. Information Technology ServicesTechnology Services Elucid Bioimaging is a medical technology company based in the United States that aims to understand and treat the underlying cause of heart attacks and strokes, specifically subclinical atherosclerosis. The company is based in Boston, MA and was founded in 2009 by Andrew Buckler. The company uses AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with known or suspected cardiovascular disease. Elucid Bioimaging's proprietary software, Vascucap, is the first tool to quantify atherosclerotic plaque against histology, deliver key arterial measures, and provide 3D visualization to inform the risk of events such as stroke or heart attack. Vascucap's unique information informs better treatment decisions by physicians, leading to better patient outcomes at a reduced cost of care. The CEO is Blake Richards. | 15 years |
| James A. Saalfield | M | - |
Still River Management Co., Inc.
 Still River Management Co., Inc. Investment ManagersFinance Still River Management Co Inc (Still River Funds) is a venture capital firm founded in 1994 by James A. Saalfield. The firm is headquartered in Waltham, Massachusetts. | 30 years |
| Joseph Tischler | M | - |
Still River Management Co., Inc.
Still River Management Co., Inc. Investment ManagersFinance Still River Management Co Inc (Still River Funds) is a venture capital firm founded in 1994 by James A. Saalfield. The firm is headquartered in Waltham, Massachusetts. | - |
| James McGowan | M | - |
Still River Management Co., Inc.
Still River Management Co., Inc. Investment ManagersFinance Still River Management Co Inc (Still River Funds) is a venture capital firm founded in 1994 by James A. Saalfield. The firm is headquartered in Waltham, Massachusetts. | - |
| Michael D. Lesh | M | 69 |
Elucid Bioimaging, Inc.
Elucid Bioimaging, Inc. Information Technology ServicesTechnology Services Elucid Bioimaging is a medical technology company based in the United States that aims to understand and treat the underlying cause of heart attacks and strokes, specifically subclinical atherosclerosis. The company is based in Boston, MA and was founded in 2009 by Andrew Buckler. The company uses AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with known or suspected cardiovascular disease. Elucid Bioimaging's proprietary software, Vascucap, is the first tool to quantify atherosclerotic plaque against histology, deliver key arterial measures, and provide 3D visualization to inform the risk of events such as stroke or heart attack. Vascucap's unique information informs better treatment decisions by physicians, leading to better patient outcomes at a reduced cost of care. The CEO is Blake Richards. | 2 years |
| R. Huennekens | M | 59 |
Elucid Bioimaging, Inc.
Elucid Bioimaging, Inc. Information Technology ServicesTechnology Services Elucid Bioimaging is a medical technology company based in the United States that aims to understand and treat the underlying cause of heart attacks and strokes, specifically subclinical atherosclerosis. The company is based in Boston, MA and was founded in 2009 by Andrew Buckler. The company uses AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with known or suspected cardiovascular disease. Elucid Bioimaging's proprietary software, Vascucap, is the first tool to quantify atherosclerotic plaque against histology, deliver key arterial measures, and provide 3D visualization to inform the risk of events such as stroke or heart attack. Vascucap's unique information informs better treatment decisions by physicians, leading to better patient outcomes at a reduced cost of care. The CEO is Blake Richards. | 1 years |
| Paul Chute | M | - |
Still River Management Co., Inc.
Still River Management Co., Inc. Investment ManagersFinance Still River Management Co Inc (Still River Funds) is a venture capital firm founded in 1994 by James A. Saalfield. The firm is headquartered in Waltham, Massachusetts. | - |
| Barbara Kroll | F | - |
Still River Management Co., Inc.
Still River Management Co., Inc. Investment ManagersFinance Still River Management Co Inc (Still River Funds) is a venture capital firm founded in 1994 by James A. Saalfield. The firm is headquartered in Waltham, Massachusetts. | 17 years |
| Sean Kelleher | M | - |
Elucid Bioimaging, Inc.
Elucid Bioimaging, Inc. Information Technology ServicesTechnology Services Elucid Bioimaging is a medical technology company based in the United States that aims to understand and treat the underlying cause of heart attacks and strokes, specifically subclinical atherosclerosis. The company is based in Boston, MA and was founded in 2009 by Andrew Buckler. The company uses AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with known or suspected cardiovascular disease. Elucid Bioimaging's proprietary software, Vascucap, is the first tool to quantify atherosclerotic plaque against histology, deliver key arterial measures, and provide 3D visualization to inform the risk of events such as stroke or heart attack. Vascucap's unique information informs better treatment decisions by physicians, leading to better patient outcomes at a reduced cost of care. The CEO is Blake Richards. | - |
| Blake Richards | M | - |
Elucid Bioimaging, Inc.
Elucid Bioimaging, Inc. Information Technology ServicesTechnology Services Elucid Bioimaging is a medical technology company based in the United States that aims to understand and treat the underlying cause of heart attacks and strokes, specifically subclinical atherosclerosis. The company is based in Boston, MA and was founded in 2009 by Andrew Buckler. The company uses AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with known or suspected cardiovascular disease. Elucid Bioimaging's proprietary software, Vascucap, is the first tool to quantify atherosclerotic plaque against histology, deliver key arterial measures, and provide 3D visualization to inform the risk of events such as stroke or heart attack. Vascucap's unique information informs better treatment decisions by physicians, leading to better patient outcomes at a reduced cost of care. The CEO is Blake Richards. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Rosol | M | 56 |
Elucid Bioimaging, Inc.
Elucid Bioimaging, Inc. Information Technology ServicesTechnology Services Elucid Bioimaging is a medical technology company based in the United States that aims to understand and treat the underlying cause of heart attacks and strokes, specifically subclinical atherosclerosis. The company is based in Boston, MA and was founded in 2009 by Andrew Buckler. The company uses AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with known or suspected cardiovascular disease. Elucid Bioimaging's proprietary software, Vascucap, is the first tool to quantify atherosclerotic plaque against histology, deliver key arterial measures, and provide 3D visualization to inform the risk of events such as stroke or heart attack. Vascucap's unique information informs better treatment decisions by physicians, leading to better patient outcomes at a reduced cost of care. The CEO is Blake Richards. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 11 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David R. Paolino
- Personal Network
